The researchers are of the view that the new drug designing strategy demonstrated by them could also be adopted to treat retroviral infections.
Since the beginning of the pandemic, more than one million patients with severe COVID-19 have been treated with Actemra/RoActemra
The agreement also had a permanent safeguard mechanism which can be resorted to in a situation of sudden surge in imports.
New subsidiaries to be established in Malaysia, Taiwan, Singapore, and Hong Kong
Spikevax has received approval by regulators in more than 70 countries, including Canada, Japan, the European Union, the UK, Israel
DS-5670 is an mRNA vaccine against Covid-19 using a novel nucleic acid delivery technology discovered by the company
Pfizer is evaluating the FDA’s comments and will work with the agency to determine an appropriate path forward
These results will be presented on 21 January at the 2022 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium
As part of Daiichi Sankyo’s 2030 vision, it plans to strengthen its oncology portfolio
The brand is now available pan-India through their distribution partner
Subscribe To Our Newsletter & Stay Updated
